I now have comprehensive material from Cummings Otolaryngology. Let me compile the full answer.
Cholesteatoma
Definition
An aural cholesteatoma is an epidermal inclusion of the middle ear or mastoid — a cystic or sheet-like accumulation of keratinizing squamous epithelium within the middle ear cleft that continuously desquamates keratin debris. The term was coined by Johannes Müller in 1838 because the white-yellow keratin flakes resemble cholesterol crystals (though cholesterol is only a minor component). Cruveilhier first described it as a "pearly tumor" of the temporal bone.
Annual incidence: 3–15/100,000 in children; 9–13/100,000 in adults.
Classification
1. Congenital Cholesteatoma
- Arises from retained embryonic keratinizing epithelial rests within the middle ear — specifically from an epidermoid formation (Michaels' epidermoid) in the anterior tympanum that normally involutes by 33 weeks' gestation
- Appears as a white cystic structure medial to an intact tympanic membrane, without prior history of otitis media, perforation, or ear surgery
- More common in children; bilateral cases reported; possible genetic contribution
Potsic Staging System for Congenital Cholesteatoma:
| Stage | Description | Residual Risk |
|---|
| I | Limited to one quadrant | Low |
| II | Multiple quadrants, no ossicular involvement | Moderate |
| III | Ossicular involvement, no mastoid extension | Significant |
| IV | Mastoid involvement | 67% residual disease |
Congenital cholesteatoma: white, cystic mass visible behind an intact tympanic membrane
2. Acquired Cholesteatoma
A. Primary Acquired (Pars Flaccida / Attic Type)
- Arises from a retraction pocket of the pars flaccida due to chronic negative middle ear pressure (Eustachian tube dysfunction)
- Pocket deepens into the epitympanum → trapped keratin cannot migrate out → cholesteatoma forms
- Classic appearance: defect adjacent to the posterosuperior TM / attic with white keratin debris and scutum erosion
- Associated with cleft palate and underdeveloped mastoid pneumatization
Primary acquired cholesteatoma: attic retraction pocket with keratin debris, eroded scutum
B. Secondary Acquired (Pars Tensa / Marginal Type)
- Keratinizing epithelium migrates through an existing perforation (usually marginal) into the middle ear
- More commonly associated with COM and longstanding TM perforations
- Often presents with a mass at the margin of a perforation
Pathogenesis Theories (Acquired)
Four classical theories, which are not mutually exclusive:
| Theory | Mechanism |
|---|
| Invagination (Retraction Pocket) | Pars flaccida retracts into attic under chronic negative ME pressure; trapped keratin → cholesteatoma. Most accepted mechanism for primary acquired type. |
| Basal Cell Hyperplasia | Basal cells of the TM proliferate and migrate into the middle ear cleft; supported by molecular markers (cytokeratin 13 & 16, EGF receptor overexpression) |
| Epithelial Ingrowth (Migration Theory) | Squamous epithelium migrates through a TM perforation; explains secondary acquired type |
| Squamous Metaplasia | Simple/cuboidal middle ear epithelium undergoes metaplastic transformation to keratinizing squamous epithelium (least supported; no human/animal model confirmation) |
| Mucosal Traction (Jackler) | Opposing mucosal surfaces propel pars flaccida into the attic via mucociliary flow and epithelial migration |
Clinical Features
Symptoms:
- Slowly progressive conductive hearing loss
- Chronic foul-smelling otorrhea (anaerobic infection of keratin debris)
- May be asymptomatic initially
- Vertigo, SNHL (labyrinthine fistula)
- Facial nerve palsy (erosion of bony fallopian canal — tympanic segment most vulnerable)
- Headache, meningismus (intracranial extension)
Otoscopic signs:
- Attic/posterosuperior defect with white keratin debris
- Aural polyp = granulation tissue at the eroding cholesteatoma margin — should be considered cholesteatoma until proven otherwise
- White mass behind intact TM (congenital)
Bone Erosion Mechanism
The classic "pressure necrosis" theory has been abandoned. Bone destruction is mediated by osteoclast activation via inflammatory cytokines. Key pathway:
- RANKL/RANK axis drives osteoclast recruitment
- Enzymes elaborated: acid phosphatase, collagenase, cathepsins, matrix metalloproteinases (MMPs)
- Intermittent osteoclastic resorption explains why some temporal bone specimens show no active erosion
Structures commonly eroded (in order of frequency):
- Scutum (lateral attic wall) — earliest sign
- Ossicular chain — incus long process most common; causes conductive HL
- Tegmen tympani (roof) → intracranial extension
- Lateral semicircular canal → labyrinthine fistula, vertigo
- Facial nerve canal (tympanic segment) → facial palsy
- Sigmoid sinus → lateral sinus thrombosis
Imaging
HRCT temporal bone:
- Soft tissue density in attic/mastoid with bony erosion
- Scutum erosion (classic sign)
- Ossicular chain destruction
- Labyrinthine involvement, tegmen dehiscence
- Essential for preoperative planning and all revision/complex cases
Axial and coronal CT of left attic cholesteatoma: eroded incus (arrow) and scutum (arrowhead)
Non-echo-planar DWI MRI:
- Sensitivity and specificity ~94% for detecting cholesteatoma
- Bright signal on DWI + low ADC = true cholesteatoma
- Increasingly used for postoperative surveillance to detect residual/recurrent disease without second-look surgery
Complications
| Type | Example |
|---|
| Local | Ossicular erosion, TM perforation |
| Labyrinthine | Fistula (LSCC most common), SNHL, vertigo |
| Facial nerve | Paresis/paralysis (tympanic segment) |
| Intracranial | Meningitis, brain abscess, epidural abscess, lateral sinus thrombosis, otitic hydrocephalus |
| Petrous apex | Gradenigo syndrome (VI nerve palsy + retro-orbital pain + otorrhea) |
Management
Surgery is the only curative treatment — no medical therapy eliminates cholesteatoma.
Surgical Approach Options:
| Procedure | Description | Pros | Cons |
|---|
| Canal Wall-Up (CWU) / Closed | Posterior tympanotomy + mastoidectomy, EAC wall preserved | Physiological ear; no cavity; good hearing reconstruction | Residual 11–27%; recurrent 5–13%; often needs second-look |
| Canal Wall-Down (CWD) / Open | Posterior canal wall removed; mastoid exteriorized | Residual/recurrent only 2–10%; recurrence easily seen | Lifelong cavity cleaning; shallow ME; meatoplasty issues; temperature dizziness |
| Radical Mastoidectomy | All ME structures removed; obliteration of ME space | Complete exteriorization | Hearing sacrifice |
| Modified Radical (Bondy) | Disease limited to attic; ossicular chain preserved | Disease-free ear; some hearing preserved | Limited indications |
| Endoscopic Ear Surgery | Transcanal endoscopic approach | Improved visualization of hidden areas; less morbidity | Learning curve; one-handed technique |
Key factors guiding choice: extent of disease, complications present, mastoid pneumatization, ET function, hearing status (both ears), patient reliability, surgeon experience.
Follow-up after CWU: Second-look surgery at 12–18 months OR non-EPI DWI MRI surveillance.
Key Pearls
- Cholesteatoma in 36% of perforated ears vs. 4% of non-perforated ears in COM temporal bones
- An aural polyp = cholesteatoma until proven otherwise
- Poorer Eustachian tube function → greater risk of recurrence post-repair
- Underdeveloped mastoid pneumatization is near-universal in both acquired and congenital cholesteatoma
- In children, even stage IV congenital cholesteatoma carries 67% residual disease — second-look is essential
- Facial nerve palsy from cholesteatoma = surgical emergency
Source: Cummings Otolaryngology Head and Neck Surgery; The Developing Human (Moore & Persaud); K.J. Lee's Essential Otolaryngology